A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of JPB898 (Proposed Nivolumab Biosimilar) and US-licensed and EU-authorized Opdivo® in Combination with Yervoy® in Participants with Untreated Advanced (Unresectable/Metastatic) Melanoma
Untreated Advanced (Unresectable/Metastatic) Melanoma
Pulau Pinang Hospital
PRINCIPAL INVESTIGATOR
SOO HOO HWOEI FEN
CONTACT
SC: Nur Shaphira Sholikin
A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics of GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU Authorized Keytruda® in Participants With Stage II and III Melanoma Requiring Adjuvant Treatment With Pembrolizumab (JIMMY-MEL)
Pulau Pinang Hospital
PRINCIPAL INVESTIGATOR
CHOONG SWEE HSIA
CONTACT
SC: Nur Madihah Yaakob
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
Eng Jie Yi
CONTACT
SC: Lim Li Fang
Mahkota Medical Centre
PRINCIPAL INVESTIGATOR
Dr Sanjeev Chandra Joshi
CONTACT
SC: Siti Zawiyah Ismail/ Justin Liu
CRC: 010-2408344/06-2852739
University Malaya Medical Centre (UMMC)
PRINCIPAL INVESTIGATOR
Dr David Lee Dai Wee
CONTACT
SC: Toh Yok Yong
Contact: 03-79492120
Sultan Ismail Hospital
PRINCIPAL INVESTIGATOR
TEH HOOI LAY
CONTACT
SC: Ahmad Firdaus Abdul Khalid, Farah Nadia Binti Mohd Hashim
Kuala Lumpur Hospital (HKL)
PRINCIPAL INVESTIGATOR
AUDI ADAWIAH BT SULAIMAN SHAH
CONTACT
SC: Puteri Nur Najwa Nor Azman, Anis Amira Aznan
General line: 03 – 2615 5555
CRC: 03 – 2615 5555 Ext. 6262 (Tel)
crc.hkl@moh.gov.my (email)
Crc Hkl / Clinical Research Centre HKL (Facebook)
National Cancer Institute (IKN)
PRINCIPAL INVESTIGATOR
SUHANA BINTI YUSAK
CONTACT
SC: Shamiza binti Ahmad Shaharudin
General line : 03 – 8892 5555
CRC: 03 – 8892 5555 Ext 5418 (Tel)
03- 8892 5622 (Fax)
A Randomized, Double-Blind Study Evaluating the Efficacy, Safety and Immunogeneticity of ABP 206 Compared with OPDIVO (Nivolumab) in Subjects with Treatment-Naive Unresectable or Metastatic Melanoma (ZINNIA)
Phase III, Line of therapy: 1st line
Pantai Hospital Kuala Lumpur
PRINCIPAL INVESTIGATOR
DR MASTURA BINTI MD YUSOF
drmasturamy@gmail.com
03 – 2296 0764
CONTACT
General Line: 03 – 2296 0888
CRC: 03-22960888 Ext.1320, 1321, 1322
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
Eng Jie Yi
CONTACT
SC: Erfan Salbi, Dafne Diana Gabriel
General line: 082 – 276666
CRC: 082-276820 (Tel)
082-276823 (Fax)
Tiong Lee Len, Admin Manager
leelen.crc@gmail.com (Email)
(Facebook)
National Cancer Institute (IKN)
PRINCIPAL INVESTIGATOR
SUHANA BINTI YUSAK
CONTACT
SC: Siti Amirah Ishak, Shamiza Ahmad Shaharudin, Hidayati Mohd, Abdul Hadi, Anis Hazirah Asmali, Yong Xian Lerk, Erda Syerena Rosli
Pulau Pinang Hospital
PRINCIPAL INVESTIGATOR
CHOONG SWEE HSIA
CONTACT
SC: Noor Aishah Robani, Yogabaanu A/P Ulaganathan
Kuala Lumpur Hospital (HKL)
PRINCIPAL INVESTIGATOR
EZNAL IZWADI BIN MOHD MAHIDIN
CONTACT
SC: Anis Atifah Mohd Hisham , Nurshahida Binti Mohd Nawi, Puteri Nur Aliah Binti Wan Faizal
General line: 03 – 2615 5555
CRC: 03 – 2615 5555 Ext. 6262 (Tel)
crc.hkl@moh.gov.my (email)
Crc Hkl / Clinical Research Centre HKL (Facebook)